0.5832
7.90%
-0.05
After Hours:
.5832
Concord Medical Services ADR stock is currently priced at $0.5832, with a 24-hour trading volume of 806.
It has seen a -7.90% decreased in the last 24 hours and a +29.63% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.6421 pivot point. If it approaches the $0.5975 support level, significant changes may occur.
Concord Medical Services ADR Stock (CCM) Financials Data
Concord Medical Services ADR (CCM) Revenue 2024
CCM reported a revenue (TTM) of $86.68 million for the quarter ending June 30, 2023, a +70.07% rise year-over-year.
Concord Medical Services ADR (CCM) Net Income 2024
CCM net income (TTM) was -$65.70 million for the quarter ending June 30, 2023, a -59.05% decrease year-over-year.
Concord Medical Services ADR (CCM) Earnings per Share 2024
CCM earnings per share (TTM) was -$1.5057 for the quarter ending June 30, 2023, a +39.23% growth year-over-year.
Concord Medical Services ADR Stock (CCM) Latest News
About Concord Medical Services ADR
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. It also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions, as well as CT scanners and ECT scanners for diagnostic imaging. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as consulting services; sells medical equipment; and researches and develops medical technology. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2017, it operated a network of 44 cooperative centers based in 30 hospitals in 29 cities across 18 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.
Cap:
|
Volume (24h):